Bladder cancer is characterized by substantial heterogeneity in the tumor immune microenvironment (TIME), which influences recurrence, progression, treatment resistance, and responses to Bacillus Calmette–Guérin (BCG), neoadjuvant chemotherapy, immune checkpoint inhibitors, and radiotherapy. This narrative review criti...
Shao-Bo Qin, Xu Yu, Shi-Shuai Zuo et al.· Frontiers in Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.